Zobrazeno 1 - 10
of 15
pro vyhledávání: '"T M, Pisansky"'
Publikováno v:
The Journal of urology. 164(5)
Autor:
T M, Pisansky, B J, Davis
Publikováno v:
Seminars in urologic oncology. 18(2)
The anatomic extent of prostate cancer has long served the role of providing prognostic information to assist in therapeutic decision-making, evaluating treatment outcomes, facilitating information exchange between medical centers, and promoting canc
Autor:
L, Cheng, R V, Lloyd, A L, Weaver, T M, Pisansky, J C, Cheville, D M, Ramnani, B C, Leibovich, M L, Blute, H, Zincke, D G, Bostwick
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 6(5)
We evaluated p27KIP1 and p21WAF1 expression in 52 patients treated by salvage radical prostatectomy and bilateral pelvic lymphadenectomy for biopsy-proven locally persistent or recurrent prostate cancer after external beam radiation therapy. We defin
Autor:
B J, Davis, M G, Haddock, T M, Wilson, H J, Rothenberg, D G, Bostwick, M G, Herman, T M, Pisansky
Publikováno v:
Techniques in urology. 6(2)
Successful treatment with ultrasound-guided transperineal interstitial permanent prostate brachytherapy (TIPPB) relies on effective radiation coverage of intraprostatic and clinically occult extraprostatic cancer. This study examines prostatectomy fi
Autor:
L, Cheng, T M, Pisansky, T J, Sebo, B C, Leibovich, D M, Ramnani, A L, Weaver, B G, Scherer, M L, Blute, H, Zincke, D G, Bostwick
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5(10)
The biological aggressiveness of lymph node-positive prostate cancer is closely linked to cancer volume in nodal metastases. We evaluated MIB-1 (Ki-67) labeling index and bcl-2 expression in primary cancer and matched nodal metastases from 138 node-p
Autor:
B J, Davis, T M, Pisansky, T M, Wilson, H J, Rothenberg, A, Pacelli, D W, Hillman, D J, Sargent, D G, Bostwick
Publikováno v:
Cancer. 85(12)
Extraprostatic extension (EPE) is an unfavorable prognostic factor in patients with prostate carcinoma. Prior studies have reported the linear extent of EPE measured circumferentially along the edge of the prostate. In this study, the authors defined
Autor:
L, Cheng, T J, Sebo, J C, Cheville, T M, Pisansky, J, Slezak, E J, Bergstralh, A, Pacelli, R M, Neumann, H, Zincke, D G, Bostwick
Publikováno v:
Cancer. 85(6)
The biologic changes in recurrent prostate carcinoma following radiation therapy are not fully understood. The authors sought to determine the level of p53 protein overexpression and its association with cellular proliferation (Ki-67 labeling index),
Autor:
L, Cheng, T J, Sebo, J, Slezak, T M, Pisansky, E J, Bergstralh, R M, Neumann, K A, Iczkowski, H, Zincke, D G, Bostwick
Publikováno v:
Cancer. 83(10)
Salvage radical prostatectomy is a treatment option for patients with recurrent cancer following radiation therapy. This study was conducted to identify predictors of survival for patients treated with salvage radical prostatectomy.The authors studie
Autor:
L R, Coia, B D, Minsky, M J, John, D, Haller, J, Landry, T M, Pisansky, C G, Willet, I, Mahon, J, Owen, G E, Hanks
Publikováno v:
Radiation medicine. 16(4)
The Patterns of Care Study (PCS) of the American College of Radiology periodically develops a decision tree and current management guidelines for major malignancies where radiation has an important role. The decision tree is a framework which depicts
Autor:
J R, Srigley, R V, Hutter, A B, Gelb, D E, Henson, G, Kenney, B F, King, S, Raziuddin, T M, Pisansky
Publikováno v:
Cancer. 80(5)